190 related articles for article (PubMed ID: 16762011)
21. Gender differences in human immunodeficiency virus-related oral lesions: an Italian study.
Campisi G; Pizzo G; Mancuso S; Margiotta V
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 May; 91(5):546-51. PubMed ID: 11346733
[TBL] [Abstract][Full Text] [Related]
22. Prevalence of oral lesions in HIV patients related to CD4 cell count and viral load in a Venezuelan population.
Bravo IM; Correnti M; Escalona L; Perrone M; Brito A; Tovar V; Rivera H
Med Oral Patol Oral Cir Bucal; 2006 Jan; 11(1):E33-9. PubMed ID: 16388291
[TBL] [Abstract][Full Text] [Related]
23. Oral white patches in a national sample of medical HIV patients in the era of HAART.
Marcus M; Maida CA; Freed JR; Younai F; Coulter ID; Der-Martirosian C; Liu H; Freed B; Guzmán-Becerra N; Shapiro M
Community Dent Oral Epidemiol; 2005 Apr; 33(2):99-106. PubMed ID: 15725172
[TBL] [Abstract][Full Text] [Related]
24. Occult hepatitis B in persons infected with HIV is associated with low CD4 counts and resolves during antiretroviral therapy.
Cohen Stuart JW; Velema M; Schuurman R; Boucher CA; Hoepelman AI
J Med Virol; 2009 Mar; 81(3):441-5. PubMed ID: 19152397
[TBL] [Abstract][Full Text] [Related]
25. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].
Panel de expertos de Gesida y Plan Nacional sobre el Sida
Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):222-35. PubMed ID: 19246124
[TBL] [Abstract][Full Text] [Related]
26. Mode of HIV transmission associated with risk of oral lesions in HIV-infected subjects in Thailand.
Nittayananta W; Chanowanna N; Winn T
J Oral Pathol Med; 2010 Feb; 39(2):195-200. PubMed ID: 20002981
[TBL] [Abstract][Full Text] [Related]
27. Prevalence of oral hairy leukoplakia in 120 pediatric patients infected with HIV-1.
Dias EP; Israel MS; Silva Junior A; Maciel VA; Gagliardi JP; Oliveira RH
Braz Oral Res; 2006; 20(2):103-7. PubMed ID: 16878201
[TBL] [Abstract][Full Text] [Related]
28. Surgical outcomes in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy.
Horberg MA; Hurley LB; Klein DB; Follansbee SE; Quesenberry C; Flamm JA; Green GM; Luu T
Arch Surg; 2006 Dec; 141(12):1238-45. PubMed ID: 17178967
[TBL] [Abstract][Full Text] [Related]
29. Retrospective analysis of the clinical behavior of oral hairy leukoplakia in 215 HIV-seropositive patients.
Vale DA; Martins FM; Silva PH; Ortega KL
Braz Oral Res; 2016 Nov; 30(1):e118. PubMed ID: 27901200
[TBL] [Abstract][Full Text] [Related]
30. A random clinical trial study to assess the efficiency of topical applications of podophyllin resin (25%) versus podophyllin resin (25%) together with acyclovir cream (5%) in the treatment of oral hairy leukoplakia.
Moura MD; Guimarães TR; Fonseca LM; de Almeida Pordeus I; Mesquita RA
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Jan; 103(1):64-71. PubMed ID: 17178496
[TBL] [Abstract][Full Text] [Related]
31. [Epidemiology of primary drug resistance in chronically HIV-infected patients in Nordrhein-Westfalen, Germany, 2001-2005].
Oette M; Kaiser R; Däumer M; Fätkenheuer G; Rockstroh JK; Knechten H; Mitrenga D; Beerenwinkel N; Sagir A; Pfister H; Häussinger D
Dtsch Med Wochenschr; 2007 May; 132(18):977-82. PubMed ID: 17457780
[TBL] [Abstract][Full Text] [Related]
32. Oral lesions in HIV infected individuals from Ribeirão Preto, Brazil.
Lourenço AG; Figueiredo LT
Med Oral Patol Oral Cir Bucal; 2008 May; 13(5):E281-6. PubMed ID: 18449110
[TBL] [Abstract][Full Text] [Related]
33. Lack of evidence for local immune activity in oral hairy leukoplakia and oral wart lesions.
Lilly EA; Cameron JE; Shetty KV; Leigh JE; Hager S; McNulty KM; Cheeks C; Hagensee ME; Fidel PL
Oral Microbiol Immunol; 2005 Jun; 20(3):154-62. PubMed ID: 15836516
[TBL] [Abstract][Full Text] [Related]
34. Oral hairy leukoplakia in two children with perinatally acquired HIV-1 infection.
Mannelli F; Galli L; Ficarra G; Romagnoli P; Vierucci S; de Martino M
Pediatr AIDS HIV Infect; 1995 Feb; 6(1):21-3. PubMed ID: 11361738
[TBL] [Abstract][Full Text] [Related]
35. Fatigue among HIV-infected patients in the era of highly active antiretroviral therapy.
Henderson M; Safa F; Easterbrook P; Hotopf M
HIV Med; 2005 Sep; 6(5):347-52. PubMed ID: 16156883
[TBL] [Abstract][Full Text] [Related]
36. [Investigation of anti-R7V antibodies in HIV-infected patients under highly active antiretroviral therapy].
Ergünay K; Altinbaş A; Calik Başaran N; Unal S; Us D; Karabulut E; Ustaçelebi S
Mikrobiyol Bul; 2008 Jul; 42(3):413-9. PubMed ID: 18822884
[TBL] [Abstract][Full Text] [Related]
37. Prevalence of oral and perioral manifestations in HIV positive adults at Tikur Anbessa Teaching Hospital Addis Ababa, Ethiopia.
Guteta S; Feleke Y; Fekade D; Neway M; Diro E
Ethiop Med J; 2008 Oct; 46(4):349-57. PubMed ID: 19271399
[TBL] [Abstract][Full Text] [Related]
38. Oro-facial lesions and CD4 counts associated with HIV/AIDS in an adult population in Oyo State, Nigeria.
Adurogbangba MI; Aderinokun GA; Odaibo GN; Olaleye OD; Lawoyin TO
Oral Dis; 2004 Nov; 10(6):319-26. PubMed ID: 15533205
[TBL] [Abstract][Full Text] [Related]
39. Influence of antiretroviral therapy on oxidative stress and cardiovascular risk: a prospective cross-sectional study in HIV-infected patients.
Masiá M; Padilla S; Bernal E; Almenar MV; Molina J; Hernández I; Graells ML; Gutiérrez F
Clin Ther; 2007 Jul; 29(7):1448-55. PubMed ID: 17825696
[TBL] [Abstract][Full Text] [Related]
40. Oral lesions in HIV-positive dental patients--one more argument for tobacco smoking cessation.
Sroussi HY; Villines D; Epstein J; Alves MC; Alves ME
Oral Dis; 2007 May; 13(3):324-8. PubMed ID: 17448217
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
